LATEST RESEARCH: Avastin vs. Lucentis for Wet AMD: Early Results.
In: Vision, 2012, S. 47-47
report
Zugriff:
The article focuses on a two-year clinical trial which suggests that bevacizumab (Avastin) is as effective as ranibizumab (Lucentis) for treating neovascular age-related macular disease.
Titel: |
LATEST RESEARCH: Avastin vs. Lucentis for Wet AMD: Early Results.
|
---|---|
Autor/in / Beteiligte Person: | Bressler, Susan B. ; Quigley, Harry A. ; Schein, Oliver D. |
Zeitschrift: | Vision, 2012, S. 47-47 |
Veröffentlichung: | 2012 |
Medientyp: | report |
ISBN: | 978-0-929661-26-1 (print) |
ISSN: | 1542-1910 (print) |
Schlagwort: |
|
Sonstiges: |
|